Cargando…
Vogt–Koyanagi–Harada Disease, a Rare Entity in Spain: The Challenge of Worldwide Immigration and Globalization
Vogt–Koyanagi–Harada disease is rare, mediated by autoimmune melanocyte inflammation and facilitated by genetic predisposition([1–3]). The main clinical features include uveitis, meningitis, tinnitus and sensorineural deafness, and skin and hair depigmentation. It usually develops in four consecutiv...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346778/ https://www.ncbi.nlm.nih.gov/pubmed/30756049 http://dx.doi.org/10.12890/2018_000886 |
Sumario: | Vogt–Koyanagi–Harada disease is rare, mediated by autoimmune melanocyte inflammation and facilitated by genetic predisposition([1–3]). The main clinical features include uveitis, meningitis, tinnitus and sensorineural deafness, and skin and hair depigmentation. It usually develops in four consecutive stages: prodromal, acute uveitic, convalescent, and chronic or recurrent([4]). In view of the first two stages, the differential diagnosis takes into account uveo-meningeal syndromes. Treatment is based on high dose corticosteroids. We present the case of a 14-year-old girl admitted to hospital with fever, progressive uveo-meningeal symptoms, and sensorineural hearing loss. After work-up, the final diagnosis of Vogt–Koyanagi–Harada disease was made. LEARNING POINTS: Vogt–Koyanagi–Harada disease should be considered when a patient presents with uveo-meningeal syndromes, particularly in pigmented ethnic groups. Acute bilateral uveitis should raise suspicion of Vogt–Koyanagi–Harada disease. Early stage diagnosis leads to prompt appropriate treatment and improves patient outcomes. |
---|